首页> 外国专利> modified ankara vaccinia virus, genome, cell, methods for culturing a mva virus, for producing a mva virus and for producing a recombinant mva virus, pharmaceutical composition, vaccine, mva virus or genome, and nucleic acid molecule

modified ankara vaccinia virus, genome, cell, methods for culturing a mva virus, for producing a mva virus and for producing a recombinant mva virus, pharmaceutical composition, vaccine, mva virus or genome, and nucleic acid molecule

机译：修饰的安卡拉痘苗病毒，基因组，细胞，mva病毒的培养方法，mva病毒的生产和重组mva病毒的生产方法，药物组合物，疫苗，mva病毒或基因组以及核酸分子

页面导航

摘要
著录项
相似文献

摘要

1/1 summary “modified ankara vaccinia viruses, genome, cell, methods to grow a mva virus, to produce a mva virus and to produce a recombinant mva virus, The pharmaceutical composition, vaccine, virus mva or genome, and nucleic acid molecule. The present invention relates to a novel modified ankara vaccinia virus (mva). The present invention also relates to a method for cultivating said mva virus and to a method for producing said mva virus. furthermore, the present invention relates to a pharmaceutical composition comprising said mva virus and one or more pharmaceutical excipient (s), diluent (s), and / or carrier (s). (s) acceptable (acceptable). furthermore, the present invention relates to a vaccine comprising said mva virus. in addition, the present invention relates to said mva virus for use in medicine.

机译：1/1摘要“经修饰的安卡拉痘苗病毒，基因组，细胞，生产mva病毒，生产mva病毒和生产重组mva病毒的方法，药物组合物，疫苗，病毒mva或基因组以及核酸分子。本发明涉及新的修饰的安卡拉痘苗病毒（mva）。本发明还涉及培养所述mva病毒的方法和产生所述mva病毒的方法。此外，本发明涉及药物组合物，其包含所述mva病毒和一种或多种药物赋形剂，稀释剂和/或载体。（s）可以接受（acceptable）。此外，本发明涉及包含所述mva病毒的疫苗。另外，本发明涉及用于医学的所述mva病毒。

著录项

公开/公告号BR112015006798A2

专利类型
公开/公告日2017-11-21

原文格式PDF
申请/专利权人 PROBIOGEN AG;
展开▼

申请/专利号BR20151106798
发明设计人 INGO JORDAN;VOLKER SANDIG;
展开▼

申请日2012-09-28
分类号C12N7/08;C12N15/86;
国家 BR
入库时间 2022-08-21 12:54:00

相似文献

专利
外文文献
中文文献